Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.95
-0.1800-8.45%
Post-market: 1.950.0003+0.02%19:31 EDT
Volume:4.18M
Turnover:8.41M
Market Cap:72.98M
PE:-1.33
High:2.14
Open:2.13
Low:1.95
Close:2.13
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:0.53
T/O Rate:23.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.64
PE(LYR):-1.45

Loading ...

Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 07, 2023

Major Issues Report

8-K - Current report
Feb 01, 2023

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2023

Major Issues Report

8-K - Current report
Jan 31, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 23, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 20, 2023

Major Issues Report

8-K - Current report
Jan 06, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 06, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 04, 2023

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 11, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 15, 2022

Major Issues Report

8-K - Current report
Aug 18, 2022

Major Issues Report

8-K - Current report